Clinical trials of biomastim

This paper gives production tests results of Biomastim which contains probiotic strains of Bacillus subtilis В-5225 (not less than 1х10 CFU in 1 cm ) and Enterococcus faecium (not less than 1х10 CFU in 1 cm ) and the Belgian production (“Chrisal” company) drug-analogue performance indicators - “HD Udder Stabilizer” drug (contains Bacillus subtilis spore forms). By the 14th day of Biomastim use cows incidence was 10,4% when in control group it was 12,5%. By the 45th day of use in the experimental group it was 2,1% less cows with latent mastitis than in the control group (8,3% and 10,4% respectively). Udder nipple cracks examination shows, that during the whole experiment this disease was decreasing in the experimental group and averaged 18,03%, when in the HD Udder Stabilizer group udder nipple cracks were in 19,47% of cases. Based on these experiments we proved, that Biomastim is an effective clinical and latent mastitis prevention drug. It should be noted, that Biomastim is ecologically clean and during milk quality research any abnormalities were not established. Somatic cell count in the experimental group did not exceed the physiological norm.